首页 | 本学科首页   官方微博 | 高级检索  
检索        

肝转移癌的DSA表现及介入性治疗
引用本文:王振亭,孔华富,左玉宽,黎涛.肝转移癌的DSA表现及介入性治疗[J].医学影像学杂志,1999(1).
作者姓名:王振亭  孔华富  左玉宽  黎涛
作者单位:山东省医学影像学研究所!济南市 250021(王振亭,孔华富,左玉宽),济南市中心医院 (黎涛)
摘    要:目的 研究肝转移癌DSA表现及血管内介入治疗效果。材料和方法 51例肝转移癌均行肝动脉造影,再行抗癌药物灌注或栓塞。结果 富血供型 20例(39.2%),等血供型 9例(17.7%),乏协供型 22例(43.1%)。肿瘤形态:结节状 33例;囊状4例;斑片状14例。治疗后92.2%病人症状减轻,56.8%的肿瘤较前缩小,半年、1年、2年、3年存活率分别为90.2%、52.9%、22.6%及12.5%。结论 DSA及其介入性治疗为肝转移瘤的一种有效的诊断和非手术治疗方法。

关 键 词:肝转移癌  数字减影血管造影  肝动脉  灌注  栓塞治疗

The DSA Characteristics and the Transluminal Therapy of Hepatic Metastatic Carcinoma
Wang Zhenting,Kong Huafu,Zuo Yuknan,et al..The DSA Characteristics and the Transluminal Therapy of Hepatic Metastatic Carcinoma[J].Journal of Medical Imaging,1999(1).
Authors:Wang Zhenting  Kong Huafu  Zuo Yuknan  
Abstract:Purpose To evaluate the digital subtraction angiography(DSA) characteristics and the transluminal therapy of hepatic metastatic carcinoma. Materials and methods Selective hepatic arteriography local chemiotherapy or chemoembolization were successfully performed in all 51 patients. Results The hypervascular tumor was showed in 20 cases(39. 2% ), isovascular in 9 cases (17. 7 % ),hypovascular in 22 cases (43.1 % ). The tumors in 33 cases (64.7% ) were of nodular appearance,those in 4 cases (7.8 %) of cryptomere and in 14 (27. 5%) of plaque type. The half-year, 1 -year, 2 --year, 3--year survival rate after translumial therapy were 90. 2%, 52. 9 %. 22. 6 %, 12.5% respectively. Conclusion UDSA is one of important diagnostic methods and transluminal chemotherapy is an effective treatment for hepatic metastatic carcinoma.
Keywords:Metastases  Hepatic angioraphy  Chemioembolization  Translumial
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号